ApolloMD passes $1.5bn in patient medical debt relief since 2018

ApolloMD, a clinician-led practice management organisation headquartered in Atlanta, has announced it has surpassed $1.5 billion in patient medical debt elimination since 2018, through an ongoing three-way arrangement with accounts receivable specialist Cascade365 and non-profit Undue Medical Debt.

The mechanism works as follows: Cascade365 identifies eligible patient accounts within ApolloMD's portfolio; those accounts are then passed to Undue Medical Debt, which purchases bundled debt portfolios at a fraction of their face value and cancels the balances outright. Patients whose incomes fall at or below 400% of the federal poverty line, or whose medical debt represents 5% or more of their annual income, qualify for forgiveness without any action required on their part.

"Our responsibility to patients does not end when they leave the hospital," said Yogin Patel, MD MBA, CEO of ApolloMD. "The financial burden of healthcare can have a real impact on a patient's mental and physical wellbeing."

How the model works

Undue Medical Debt, a 501(c)(3) founded in 2014 by former debt collectors, reports it has now abolished more than $40 billion in medical debt across its full programme, benefiting over 27 million families. The organisation acquires debt in bulk and claims an average conversion rate of roughly $100 of debt relief per $1 donated — a function of the steep discounts at which distressed medical receivables trade in the secondary market.

Cascade365 CEO Lee Brockett described the milestone as evidence of a "coordinated approach" that aligns operational processes across providers and relief organisations to produce outcomes that go beyond conventional financial metrics. Ruth Landé, Vice President of Provider Relations at Undue Medical Debt, said the relief often reaches patients "out of the blue" — unsolicited letters informing them that a balance has been cancelled.

Market and policy context

Medical debt is a structurally embedded problem in the US healthcare system. Estimates from the Consumer Financial Protection Bureau have placed outstanding medical debt on credit reports in the hundreds of billions of dollars, though the precise aggregate figure is contested. The Biden administration moved in 2024 to restrict the reporting of medical debt on consumer credit files, and several states have enacted their own debt-relief or non-reportability statutes; the policy environment under the current administration remains in flux.

For physician practice management groups, debt forgiveness programmes of this kind serve a dual commercial and reputational purpose. Eliminating unrecoverable receivables at a bulk discount clears balance sheets while producing community-benefit metrics that matter to hospital partners weighing contract renewals. Competitors in the practice management space — including large national groups and private-equity-backed operators — are watching the model for scalability signals.

ApolloMD operates across emergency medicine, hospital medicine, anaesthesia, and revenue cycle management, and has been partnering with hospitals for more than four decades. The company did not disclose what proportion of the $1.5 billion represents debt originated within the current partnership window versus historical ApolloMD accounts, nor did it provide data on patient recidivism rates or re-engagement with care following debt relief — figures that would meaningfully strengthen the public health case for the model.